Edition:
United States

Insider Trading: aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

3.90USD
20 Sep 2017
Change (% chg)

$0.05 (+1.30%)
Prev Close
$3.85
Open
$3.80
Day's High
$4.00
Day's Low
$3.80
Volume
32,374
Avg. Vol
5,596
52-wk High
$4.45
52-wk Low
$2.12

All Insider Trades
Trading Date Name Title Type Shares Traded Price
30 Aug 2017

Mendlein (John D)

Chief Executive Officer Buy 37,736 $2.65
30 Aug 2017

Schimmel (Paul R Ph.D.)

Director Buy 94,336 $2.65
23 Apr 2017

Mendlein (John D)

Chief Executive Officer Buy 124 $3.00
19 Apr 2017

Mendlein (John D)

Chief Executive Officer Buy 1,552 $3.00
17 Apr 2017

Mendlein (John D)

Chief Executive Officer Buy 1,000 $3.00
20 Dec 2016

Schimmel (Paul R Ph.D.)

Director Buy 10,000 $2.28
19 Dec 2016

Amanullah (Ashraf)

Officer Buy 11,000 $2.25
19 Dec 2016

Schimmel (Paul R Ph.D.)

Director Buy 15,000 $2.27
18 Dec 2016

Mendlein (John D)

Chief Executive Officer Buy 69,000 $2.20
15 Dec 2016

Schimmel (Paul R Ph.D.)

Director Buy 10,000 $2.40
14 Dec 2016

Schimmel (Paul R Ph.D.)

Director Buy 40,000 $2.50
22 Sep 2016

Schimmel (Paul R Ph.D.)

Director Gift 12,572 $0.00
22 Sep 2016

Schimmel (Paul R Ph.D.)

Director Gift 12,572 $0.00
10 May 2016

Matsuoka (Grove)

Officer Buy 10,000 $3.03
8 May 2016

Matsuoka (Grove)

Officer Buy 2,412 $3.08
13 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 33,619 $4.22
13 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 32,600 $4.14
12 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 9,835 $3.85
11 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 2,581 $3.75
11 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 6,546 $3.70
10 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 5,300 $3.45
10 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 27,359 $3.59
7 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 85,000 $3.22
6 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 40,000 $3.19
5 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 25,000 $3.20

Institutional Holders

% Shares Owned: 94.38%
# of Holders: 46
Total Shares Held: 22,499,267
3 Mo. Net Change: 4,052,546
# New Positions: 4
# Closed Positions: 10
# Increased Positions: 11
# Reduced Positions: 19
# Net Buyers: -8

Officers & Directors

Name Age Since Current Position

John Clarke

63 2005 Independent Chairman of the Board

John Mendlein

57 2015 Chief Executive Officer, Director

John Blake

40 2017 Senior Vice President - Finance

David King

58 2016 Senior Vice President - Research

Grove Matsuoka

58 2016 Senior Vice President, Product Programs and Planning

Ashraf Amanullah

49 2015 Vice President, Biologics Development and Manufacturing

Sanuj Ravindran

45 2016 Chief Business Officer

Sanjay Shukla

45 2016 Chief Medical Officer

Timothy Coughlin

50 2017 Director

Jeffrey Hatfield

2017 Director

Srinivas Akkaraju

48 2015 Independent Director

James Blair

77 2010 Independent Director

Mark Goldberg

62 2015 Independent Director

Amir Nashat

44 2006 Independent Director

Paul Schimmel

76 2005 Independent Director